This inventor holds 5 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1976-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JA (1976 - 1977)
- Wako, JA (1977)
- Wako, JP (1980)
- Saitama, JP (1987)
Company Filing History:
Years Active: 1976-1987
Title: Keisuke Murakami: Innovator in Antimicrobial Research
Introduction
Keisuke Murakami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antimicrobial research, holding a total of 5 patents. His work focuses on developing innovative cephalosporin derivatives that exhibit excellent antimicrobial activity.
Latest Patents
Among his latest patents is the invention of a 7-methoxy cephalosporin derivative. This compound is represented by a specific general formula, wherein R.sup.1 can be a particular group or a HOOC-- group, R.sup.2 denotes a nitrogen-containing heterocyclic group, and M represents either a hydrogen atom or a cation residue that forms a salt. Another notable patent is related to the process of producing 7-methoxy cephalosporins, which also showcases the same antimicrobial properties.
Career Highlights
Keisuke Murakami is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to advance his research in pharmaceuticals. His innovative approach has led to the development of compounds that have the potential to significantly impact the treatment of bacterial infections.
Collaborations
Throughout his career, Murakami has collaborated with esteemed colleagues such as Takashi Osono and Shunichi Watanabe. These partnerships have fostered a collaborative environment that enhances the research and development of new antimicrobial agents.
Conclusion
Keisuke Murakami's contributions to antimicrobial research through his innovative patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile